Stop loss
Test for diagnosis and treatment of diabetes

Quotient, a company founded in 2002 as a spin off of Chelsea Instruments Ltd., has developed, produced and marketed the Quo-Test, an apparatus for measuring the concentration of glycated hemoglobin, a parameter of great importance in keeping periodically monitored the state of compensation of diabetic patients (diabetes is the 4th / 5th cause of death in developed countries and affects 250 million people).

Date of investment June, 2009

Stop loss June, 2014

Offices Whalton on Thames, UK

Life Science